Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane

Study Title

Efficacy and Safety Comparison of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients

Teva Identifier

ABS-AS-202

ClinicalTrials.gov Identifier

NCT01899144

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

07/01/2013 - 10/01/2013

Phase

Phase 2

Study Type

Interventional